Targazyme's Grant

Targazyme raised a round of funding on July 27, 2015. Investors include National Cancer Institute.

Targazyme is a San Diego-based, clinical-stage biopharmaceutical company developing novel enzyme-based platform technologies and products to improve clinical efficacy outcomes for cell therapy, immuno…

Articles about Targazyme's Grant: